---
title: "mkjh"
type: "Profile"
locale: "en"
url: "https://longbridge.com/en/profiles/25461045.md"
datetime: "2026-08-25T14:43:49.261Z"
locales:
  - [en](https://longbridge.com/en/profiles/25461045.md)
  - [zh-CN](https://longbridge.com/zh-CN/profiles/25461045.md)
  - [zh-HK](https://longbridge.com/zh-HK/profiles/25461045.md)
generator: "portal-rs"
---

# mkjh — Longbridge Community Profile

## User Info

| Item | Detail |
|------|--------|
| Name | mkjh |
| Profile URL | https://longbridge.com/en/profiles/25461045 |
| Followers | 1 |
| Following | 1 |
| Posts | 5 |
| Topics | 5 |
| Likes Received | 11 |

## Recent Activities (5)

- [Over the past week to two weeks, the stock has shown small fluctuations, mostly trading around $1.00](https://longbridge.com/en/topics/100000000458162.md) — *2026-02-07T17:22:28.000Z* (👍 5)
- [Fate Therapeutics presented updated clinical data at ACR Convergence 2025 showing immune system remo](https://longbridge.com/en/topics/100000000458142.md) — *2026-02-07T17:18:21.000Z* (👍 6)
- [Fate Therapeutics has released updated clinical data for its lead off‑the‑shelf CAR T‑cell therapy, ](https://longbridge.com/en/topics/100000000442876.md) — *2026-02-03T08:07:39.000Z*
- [$Fate Therap(FATE.US)Its key program, FT819, is an early-stage CAR-T therapy showing encouraging saf](https://longbridge.com/en/topics/100000000439077.md) — *2026-02-01T14:40:42.000Z*
- [Fate Therapeutics remains a high-risk, high-reward biotech play, with recent developments mainly cen](https://longbridge.com/en/topics/100000000439065.md) — *2026-02-01T14:37:58.000Z* (💬 1)

## Following (1)

- [BrandonNa](https://longbridge.com/en/profiles/25460819.md)

## Recently Viewed Stocks (1)

- [FATE.US](https://longbridge.com/en/quote/FATE.US.md)


---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**